HK1197085A1 - Genetic variants for predicting risk of breast cancer - Google Patents
Genetic variants for predicting risk of breast cancerInfo
- Publication number
- HK1197085A1 HK1197085A1 HK14110581A HK14110581A HK1197085A1 HK 1197085 A1 HK1197085 A1 HK 1197085A1 HK 14110581 A HK14110581 A HK 14110581A HK 14110581 A HK14110581 A HK 14110581A HK 1197085 A1 HK1197085 A1 HK 1197085A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- breast cancer
- genetic variants
- predicting risk
- predicting
- risk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IS50016 | 2011-06-16 | ||
PCT/IS2012/050009 WO2012172575A1 (fr) | 2011-06-16 | 2012-06-14 | Variants génétiques pour prédire le risque de cancer du sein |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1197085A1 true HK1197085A1 (en) | 2015-01-02 |
Family
ID=47356620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14110581A HK1197085A1 (en) | 2011-06-16 | 2014-10-23 | Genetic variants for predicting risk of breast cancer |
Country Status (4)
Country | Link |
---|---|
US (1) | US20140329719A1 (fr) |
EP (1) | EP2721180A4 (fr) |
HK (1) | HK1197085A1 (fr) |
WO (1) | WO2012172575A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10323285B2 (en) * | 2013-09-09 | 2019-06-18 | Nantomics, Llc | Proteomics analysis and discovery through DNA and RNA sequencing, systems and methods |
CN104035889B (zh) * | 2014-06-18 | 2017-02-22 | 中国人民解放军信息工程大学 | 一种多态路由派生方法及系统 |
MX2017006028A (es) * | 2014-11-06 | 2018-01-23 | Ancestryhealth Com Llc | Prediccion de resultados de salud. |
WO2016100049A1 (fr) | 2014-12-18 | 2016-06-23 | Edico Genome Corporation | Transistor à effet de champ chimiquement sensible |
US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
WO2017201081A1 (fr) | 2016-05-16 | 2017-11-23 | Agilome, Inc. | Dispositifs à fet au graphène, systèmes et leurs méthodes d'utilisation pour le séquençage d'acides nucléiques |
WO2019075251A2 (fr) * | 2017-10-12 | 2019-04-18 | Nantomics, Llc | Score de cancer pour l'évaluation et la prévision de réponse à partir de fluides biologiques |
TWI661198B (zh) * | 2018-01-26 | 2019-06-01 | 長庚大學 | 診斷或預斷人類口腔癌的方法 |
CN113707222A (zh) * | 2021-07-28 | 2021-11-26 | 邢传华 | 用于预测预定疾病风险的方法、计算设备和存储介质 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070092900A1 (en) * | 2005-10-26 | 2007-04-26 | Stacey Simon N | Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer |
EP2540840A3 (fr) * | 2007-03-26 | 2013-05-15 | Decode Genetics EHF. | Variants génétiques du CHR16 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein |
MX2009012722A (es) * | 2007-05-25 | 2009-12-11 | Decode Genetics Ehf | Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama. |
WO2009042975A1 (fr) * | 2007-09-26 | 2009-04-02 | Navigenics, Inc. | Procédés et systèmes pour l'analyse génomique à l'aide de données ancestrales |
WO2009097270A2 (fr) * | 2008-01-28 | 2009-08-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Procédé de détermination du risque du cancer du sein |
JP2011527565A (ja) * | 2008-07-07 | 2011-11-04 | ディコーデ ジェネテクス イーエイチエフ | 乳癌のリスクアセスメントのための遺伝的変異 |
-
2012
- 2012-06-14 WO PCT/IS2012/050009 patent/WO2012172575A1/fr unknown
- 2012-06-14 EP EP12800878.6A patent/EP2721180A4/fr not_active Withdrawn
- 2012-06-14 US US14/126,828 patent/US20140329719A1/en not_active Abandoned
-
2014
- 2014-10-23 HK HK14110581A patent/HK1197085A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2721180A1 (fr) | 2014-04-23 |
US20140329719A1 (en) | 2014-11-06 |
EP2721180A4 (fr) | 2015-09-02 |
WO2012172575A1 (fr) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276488B (en) | A method for predicting breast cancer prognosis | |
HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
EP2686443A4 (fr) | Variants génétiques utiles pour l'estimation du risque d'un cancer de la thyroïde | |
IL228738A0 (en) | Antibodies for cancer treatment | |
HK1254859A1 (zh) | 治療乳腺癌的方法 | |
HK1201413A1 (en) | Treatment of breast cancer | |
HK1197182A1 (en) | Cancer immunotherapy | |
EP2691547A4 (fr) | Prédicteurs d'expression génique pour le pronostic du cancer | |
EP2698634A4 (fr) | Biomarqueur pour le cancer du sein | |
GB201102014D0 (en) | Method for predicting risk of developing cancer | |
EP2648754A4 (fr) | Méthodes d'inhibition de la métastase d'un cancer | |
EP2707710A4 (fr) | Diagnostic de cancer | |
IL228430A0 (en) | Cancer treatment | |
GB201120860D0 (en) | Cancer immunotherapy | |
GB2510539B (en) | Biomarkers of cancer | |
EP2894477A4 (fr) | Procédé de dépistage du cancer du sein | |
EP2771695A4 (fr) | Procédé de détection de cancers du sein | |
EP2649225A4 (fr) | Biomarqueurs pour la prédiction du cancer du sein | |
EP2732287A4 (fr) | Procédés de diagnostic du cancer | |
GB201103407D0 (en) | Genetic association | |
EP2769225A4 (fr) | Marqueurs biologiques prédictifs pour le cancer du sein | |
IL229109A0 (en) | Cancer diagnosis | |
AP3297A (en) | Direct electrowinning of cobalt | |
GB201121783D0 (en) | Treatment of cancer | |
GB201222952D0 (en) | Treatent of cancer |